Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
- Status
- COMPLETED
- Phase
- PHASE3
Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study of Neoadjuvant Pembrolizumab & Lenvatinib for Resectable Stage III Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users
- Status
- COMPLETED
- Phase
- PHASE4
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Voices From the Black Community: Hepatitis C Research Participation
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab + Defactinib In Pleural Mesothelioma
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3